Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Scrip Asks… What Will Happen In Orphan Drug Pricing In The Next Five Years?

27 Feb 2017

• By Scrip Team

Wrench and coins — Are orphan drugs facing greater pricing pressures? • Source: Shutterstock

Related Content

Sanofi Sunrise Co. MyoKardia Sets Heart On Untapped Cardiomyopathy Market

12 Jan 2017

Related Companies

Sanofi Genzyme

Akari Therapeutics, Plc

MyoKardia, Inc.

Alexion Pharmaceuticals Inc.

Alexion Pharmaceuticals Inc.

Additional Topics

Rare Diseases Pricing Strategies Market Access Pricing Debate Reimbursement Commercial Scrip Asks BioPharmaceutical

More from Scrip Asks

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.